Vicarious Surgical Inc. (RBOT) is a publicly traded Healthcare sector company. As of May 21, 2026, RBOT trades at $1.92 with a market cap of $13.67M and a P/E ratio of 0.00. RBOT moved -3.52% today. Year to date, RBOT is -80.05%; over the trailing twelve months it is -96.02%. Its 52-week range spans $0.27 to $19.00. Analyst consensus is hold with an average price target of $8.75. Rallies surfaces RBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RBOT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RBOT recently traded at $1.92. Market cap is $13.67M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.92 |
| Market Cap | $13.67M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.00 |
| 52-Week Low | $0.27 |
| Volume | 53.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-63.22M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $0 | $-63.22M | $0.00 |
| 2023 | $0 | $-71.07M | $-0.49 |
| 2022 | $0 | $5.16M | $0.04 |
| 2021 | $0 | $-35.21M | $-0.36 |
5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $8.75.